Browse All

Current Filters

CLEAR FILTER x

TITLE

Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine

Retinal age gap as a predictive biomarker of future risk of Parkinson's disease